美股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

HORIZON KINETICS MEDICAL ETF

35.29

+0.33190.95%

盘后：35.300.0109+0.03%16:10 EDT

成交量：227

成交额：8,052

市值：1,658.40万

市盈率：- -

高：35.30

开：35.30

低：35.29

收：34.96

52周最高：37.90

52周最低：28.87

股本：46.99万

流通股本：46.99万

量比：0.09

换手率：0.05%

股息：0.41

股息率：1.16%

净资产收益率：--

总资产收益率：--

市净率：--

市盈率(LYR):- -

数据加载中...

总览公司新闻资讯公告

据称阿波罗正在洽谈收购强生骨科业务部门。

礼来完成对Ataibeckley收购，加速推进难治性抑郁症及其他精神健康疾病疗法研发

创新药将迎数据催化窗口！OS、PFS、ORR还都分不清楚？速查指南来了！收藏备用

重磅大会在前，创新药未有起色，什么情况？华宝基金港股通创新药ETF（520880）失守所有均线

放量普跌！有色突遭重挫，创新药跌跌不休！光模块逆市独涨，高“光”创业板人工智能ETF（159363）V型拉升

贝泰妮：注射用透明质酸钠溶液获得医疗器械注册证

东方生物：获得多项境外医疗器械注册证

九强生物：取得I型胶原氨基端延长肽测定试剂盒医疗器械注册证

麦科田赴港上市：并购拼出的医疗器械版图，暗藏多重隐忧

昂利康创新药引进项目告吹：授权合作折戟背后，主业承压研发布局遇变数

一品红痛风创新药Ⅲ期临床达到主要终点大中华区销售峰值预计达19.5亿元

无AI增长：八大精选股票

港股异动 | 创新药概念股持续调整海外利率预期反复 2026国谈收官进入结果等待期

百龙创园在昆明成立生物科技公司

港股异动 | 先健科技(01302)涨超3% LantvalTM主动脉瓣膜置换系统进入创新医疗器械特别审查程序

【券商聚焦】中信建投：医疗器械板块业绩有望逐步改善

深港携手拓全球药械市场，2026深圳国际高性能医疗器械展举行

涉IPO操纵嫌疑，香港证监会强制眼科创新药公司拨康视云停牌，最牛天使投资人富豪龚虹嘉是站台的基石投资者

国产创新药新适应症密集获批 “一药拓多域”重塑行业成长逻辑

国产创新药新适应症密集获批 “一药拓多域”重塑行业成长逻辑

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hans/stock/MEDX/news?page=4"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"MEDX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MEDX\",,,,,undefined,":{"symbol":"MEDX","market":"US","secType":"STK","nameCN":"HORIZON KINETICS MEDICAL ETF","latestPrice":35.2891,"timestamp":1789416000000,"preClose":34.9572,"halted":0,"volume":227,"hourTrading":{"tag":"盘后","latestPrice":35.3,"preClose":35.2891,"latestTime":"16:10 EDT","volume":7,"amount":247.0237,"timestamp":1789416603919,"change":0.0109,"changeRate":0.000309,"amplitude":0},"delay":0,"changeRate":0.009494467520281871,"floatShares":469946,"shares":469946,"eps":0,"marketStatus":"未开盘","change":0.3319,"latestTime":"09-14 16:00:00 EDT","open":35.3,"high":35.3,"low":35.2891,"amount":8052,"amplitude":0.000312,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1789459200000},"marketStatusCode":0,"adr":0,"exchange":"NASDAQ","adjPreClose":34.9572,"sharesOutstanding":569946,"nav":34.94,"aum":16419913.24,"dividendRate":0.01159,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":35.3,"preClose":35.2891,"latestTime":"16:10 EDT","volume":7,"amount":247.0237,"timestamp":1789416603919,"change":0.0109,"changeRate":0.000309,"amplitude":0},"volumeRatio":0.087916},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MEDX\",,,,,undefined,":{"symbol":"MEDX","floatShares":469946,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.087916,"shares":469946,"dividePrice":0.409,"high":35.3,"amplitude":0.000312,"preClose":34.9572,"low":35.2891,"week52Low":28.8652,"pbRate":"--","week52High":37.9,"institutionHeld":0,"latestPrice":35.2891,"eps":0,"divideRate":0.01159,"volume":227,"delay":0,"ttmEps":0,"open":35.3,"prevYearClose":33.2024,"prevWeekClose":34.9572,"prevMonthClose":36.417,"prevQuarterClose":36.7138,"fiveDayClose":36.6906,"twentyDayClose":35.6938,"sixtyDayClose":34.2263},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MEDX\",params:#limit:5,,,undefined,":[{"date":"2025-12-23","symbol":"MEDX","amount":0.4088,"announcedDate":"2025-12-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-23","defaultRemindTime":1766500200000,"name":"HORIZON KINETICS MEDICAL ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-24","payableDate":"2025-12-23","currency":"USD","dateTimestamp":1766466000000,"payDate":"2025-12-24"},{"date":"2024-12-24","symbol":"MEDX","amount":0.502335,"announcedDate":"2024-12-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-24","defaultRemindTime":1735050600000,"name":"HORIZON KINETICS MEDICAL ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-26","payableDate":"2024-12-24","currency":"USD","dateTimestamp":1735016400000,"payDate":"2024-12-26"},{"date":"2023-12-27","symbol":"MEDX","amount":1.379798,"announcedDate":"2023-12-26","type":"dividend","market":"US","newRecordDate":"2023-12-28","defaultRemindTime":1703687400000,"name":"HORIZON KINETICS MEDICAL ETF","recordDate":"2023-12-29","payableDate":"2023-12-28","currency":"USD","dateTimestamp":1703653200000,"payDate":"2023-12-29"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MEDX\",market:\"US\",,,undefined,":[{"executeDate":"2023-12-27","recordDate":"2023-12-28","paymentDate":"2023-12-29","value":1.379798,"currency":"USD"},{"executeDate":"2024-12-24","recordDate":"2024-12-24","paymentDate":"2024-12-26","value":0.502335,"currency":"USD"},{"executeDate":"2025-12-23","recordDate":"2025-12-23","paymentDate":"2025-12-24","value":0.4088,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"MEDX\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MEDX\",pageSize:20,pageCount:4,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2666657206","title":"据称阿波罗正在洽谈收购强生骨科业务部门。","url":"https://stock-news.laohu8.com/highlight/detail?id=2666657206","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666657206?lang=zh_cn&edition=fundamental","pubTime":"2026-09-12 06:25","pubTimestamp":1789165559,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["FTXH","LU0289739699.SGD","JNJ","LU0795875086.SGD","LU2133065610.SGD","PJP","LU0964807845.USD","XLV","IE00BGHQF631.EUR","LU1221951046.USD","RXL","JDOC","IXJ","IYH","LU0985320562.USD","LU2468319806.SGD","IE00B1BXHZ80.USD","LU1066051498.USD","LU0820562030.AUD","SG9999001440.SGD","GDOC","TRUH","BMED","LU1061106388.HKD","LU0345770993.USD","LU0943347566.SGD","MEDX","LU2487616109.SGD","SG9999001176.USD","LU1244550221.USD","IE0000B7K699.USD","LU0640476718.USD","LU2750360997.AUD","IE00BZ1G4Q59.USD","SGXZ57979304.SGD","SGXZ80539844.SGD","LU0345770308.USD","LU0210536198.USD","LU2756315664.SGD","IE000WAW04H5.SGD","LU1732800096.USD","LU0689472784.USD","IE000SO60NU8.SGD","IE00BFXG1179.USD","FHLC","IHE","LU0787776722.HKD","LU2213496289.HKD","LU1057294990.SGD","VHT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1154710349","title":"礼来完成对Ataibeckley收购，加速推进难治性抑郁症及其他精神健康疾病疗法研发","url":"https://stock-news.laohu8.com/highlight/detail?id=1154710349","media":"美股速递","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1154710349?lang=zh_cn&edition=fundamental","pubTime":"2026-09-11 21:04","pubTimestamp":1789131857,"startTime":"0","endTime":"0","summary":"礼来公司已正式完成对Ataibeckley的收购事宜。这一战略举措，旨在为那些饱受难治性抑郁症以及其他精神健康疾病困扰的患者，开辟全新的治疗路径。此项交易的落定，标志着礼来在精神健康领域的布局迈出了坚实一步。礼来此番动作，显然意在突破这一瓶颈。通过将Ataibeckley的研发资产与专业团队纳入麾下，礼来有望整合各方资源，加速相关候选药物的研发进程。礼来此举，无疑将为其在精神科药物市场的未来竞争增添重要砝码。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TRUH","LU1917777945.USD","LU1232071149.USD","IE00BWXC8680.SGD","LU0097036916.USD","IE0002141913.USD","FHLC","LU1623119135.USD","LU2023251221.USD","IE00BJJMRX11.SGD","LU2108987350.USD","LU2552382132.HKD","LU0820562030.AUD","IE00B7KXQ091.USD","BK4585","LU2361044865.SGD","SG9999014880.SGD","LU0094547139.USD","LU0471298694.HKD","LU2237443895.HKD","LU1548497426.USD","BK4534","LU2168563687.JPY","IXJ","LU2552382215.SGD","LU0689472784.USD","SG9999017495.SGD","SG9999014914.USD","IE0009355771.USD","SGXZ81514606.USD","LU0210536198.USD","LU0238689110.USD","LU1093756325.SGD","LU2471134523.USD","PPH","LU1366192091.USD","IE0004445015.USD","SGXZ57979304.SGD","LU1814569148.SGD","LU2063271972.USD","LU1983299246.USD","GB00BDT5M118.USD","LU2168564065.EUR","LU0683600562.USD","LU0889565916.HKD","LU2602419157.SGD","LU0133085943.USD","LU2089283258.USD","LU0198837287.USD","LU2089984988.USD","LU2552382058.USD","GDOC","LU0158827948.USD","LU0256863902.USD","SG9999014906.USD","LU0354030438.USD","LU0385154629.USD","IE00BFTCPJ56.SGD","LU0058720904.USD","LU0256863811.USD","LU0964807845.USD","LU1720051017.SGD","LU0289739699.SGD","LU2211815571.USD","LU2324357040.USD","LU2361044949.HKD","IE00BJJMRZ35.SGD","LU1551013425.SGD","LU2468319806.SGD","LU0320765059.SGD","LU0466842654.USD","IE00B2B36J28.USD","LU2750360641.GBP","LU0823434583.USD","SG9999018865.SGD","LU0345770308.USD","LU2756315664.SGD","IE00B1BXHZ80.USD","LU1868837300.USD","LU0203202063.USD","LU2237443622.USD","LU0354030511.USD","CANC","IE00B1XK9C88.USD","LU2089284900.SGD","LU2491050154.USD","FTXH","LU0266013472.USD","IE0001KFT4U8.USD","LU2750360997.AUD","IE00BFSS8Q28.SGD","LU0109391861.USD","SG9999014898.SGD","LU1868836591.USD","LU2361045086.USD","LU2168564495.EUR","LU0417517546.SGD","IE0005OL40V9.USD","LU0823434740.USD","LU2112291526.USD","IE0004445239.USD","LU2756315318.SGD","LU0786609619.USD","IE00BFSS7M15.SGD","LU0471298777.SGD","LU2360106947.USD","LU0096364046.USD","LU1720051108.HKD","LU2023250504.SGD","WDNA","LU0109394709.USD","LU2265009873.SGD","LU2237443465.HKD","IE00B4R5TH58.HKD","SGXZ99366536.SGD","SG9999013999.USD","SG9999015945.SGD","LU2236285917.USD","LU2106854487.HKD","IYH","IE00BN29S564.USD","MHIP","LU0316494557.USD","SG9999001176.USD","LU2491050071.SGD","SGXZ51526630.SGD","LU1280957306.USD","LU0122379950.USD","LU1057294990.SGD","LU2417539215.USD","LU2456880835.USD","LU1629891620.HKD","LU1069344957.HKD","LLY","LU0345770993.USD","THNR","LU0708995401.HKD","LU2237443978.SGD","LU2023250330.USD","IE00BJJMRY28.SGD","LU2271345857.HKD","CURE","MEDX","LU0882574139.USD","LU2746668461.USD","LU0174119429.USD","LU0323591593.USD","LU0640476718.USD","SG9999018857.SGD","LU0672654240.SGD","LU2237438978.USD","LU0114720955.EUR","LU1064131342.USD","LU2357305700.SGD","SG9999015952.SGD","LU0882574055.USD","LU1691799644.USD","IE00BJT1NW94.SGD","LU2028103732.USD","LU2168564222.USD","TMED","BK4588","SGXZ31699556.SGD","LU0106261372.USD","RXL","IE00BK4W5L77.USD","LU1267930730.SGD","LU2462157665.USD","IE00B775H168.HKD","LU0061475181.USD","XLV","IE00BK4W5M84.HKD","LU0820561818.USD","LU0320765992.SGD","HRTS","ILDR","LU1988902786.USD","LU0820561909.HKD","AGNG","LU2087625088.SGD","LU2746668974.SGD","SG9999001176.SGD","MEDI","LU2471134879.HKD","BK4516","LU0432979614.USD","BK4533","LLYX","LU1035775433.USD","LU2491049909.HKD","LU2237443549.SGD","LU0787776722.HKD","LU0943347566.SGD","LU0353189763.USD","LU2471134952.CNY","LU2111349929.HKD","LU1127390331.HKD","IE00BJLML261.HKD","BK4007","LU1323610961.USD","LU2462591350.SGD","LU1979441026.SGD","LU1974910355.USD","IE00BKDWB100.SGD","LU1989771016.USD","LU0225283273.USD","LLII","SG9999015986.USD","LU2461242641.AUD","LU0158827781.USD","LU1868837136.USD","LU1804176565.USD","LLYZ","JDOC","LU0234572021.USD","LU0456855351.SGD","LU0203201768.USD","LU1061106388.HKD","LU1093756168.USD","VHT","LU0079474960.USD","ELIS","OZEM","LU0006306889.USD","IE00BKPKM429.USD","SG9999015978.USD","LU1023059063.AUD","IHE","PJP","LU0823416689.USD","LU2213496289.HKD","LU2264538146.SGD","ELIL","LU1868836914.USD","BK4599","LU1145028129.USD","LU0353189680.USD","LU2896262040.SGD","BK4581","LU1868836757.USD","LU2237443382.USD","LU2168564149.EUR","LU1712237335.SGD","LU2471134796.USD","IE00B4JS1V06.HKD","LU1291159041.SGD","LU1551013342.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666798529","title":"创新药将迎数据催化窗口！OS、PFS、ORR还都分不清楚？速查指南来了！收藏备用","url":"https://stock-news.laohu8.com/highlight/detail?id=2666798529","media":"新浪基金","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666798529?lang=zh_cn&edition=fundamental","pubTime":"2026-09-11 19:22","pubTimestamp":1789125720,"startTime":"0","endTime":"0","summary":"创新药重磅提示！就在周六，2026年WCLC将正式开幕，康方生物、石药集团、科伦博泰生物等诸多创新药龙头公司将公布旗下核心产品临床数据。III期达到终点，意味着获批概率大幅提升，属于实质性大利好。临床试验中通常报告“中位OS”，即50%患者存活的时间。FDA加速批准程序允许基于替代终点批准药物，但上市后需完成确证性试验。FDA规定，提交后30天内若无异议，IND自动生效。以优效性为目标的头对头试验证据级别最高。权重数据截至2026.8.31。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2026-09-11/doc-inirnhrw8907408.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["IBBQ","BK1161","06978","BK1574","ORR","159992","LNGR","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666529140","title":"重磅大会在前，创新药未有起色，什么情况？华宝基金港股通创新药ETF（520880）失守所有均线","url":"https://stock-news.laohu8.com/highlight/detail?id=2666529140","media":"新浪基金","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666529140?lang=zh_cn&edition=fundamental","pubTime":"2026-09-11 19:17","pubTimestamp":1789125420,"startTime":"0","endTime":"0","summary":"100%创新药研发标的——港股通创新药ETF华宝失守所有均线，重仓A股创新药的药ETF华宝标的指数日K、周K双双五连阴。图：港股通创新药ETF华宝近6月日K走势如何看待创新药本轮调整？低位埋伏创新药，关注两大投资工具：港股通创新药ETF华宝：紧密跟踪恒生港股通创新药精选指数，100%布局创新药研发类公司，前十大权重股占比超七成，龙头属性突出，底层资产是港股，高弹性、T+0。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2026-09-11/doc-inirnhry5675751.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LNGR","MEDX","520880","FLHK","BK1574","159992","BK1161","06978","IBBQ","159316"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666452917","title":"放量普跌！有色突遭重挫，创新药跌跌不休！光模块逆市独涨，高“光”创业板人工智能ETF（159363）V型拉升","url":"https://stock-news.laohu8.com/highlight/detail?id=2666452917","media":"新浪基金","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666452917?lang=zh_cn&edition=fundamental","pubTime":"2026-09-11 19:15","pubTimestamp":1789125300,"startTime":"0","endTime":"0","summary":"有色板块领跌全市场，揽尽有色金属行业龙头的有色ETF华宝标的指数收跌4.04%失守所有均线。FCC政策落地，光通信担忧明显缓解，光模块龙头逆市走强，中际旭创逆市收涨4%，新易盛涨近3%，高“光”创业板人工智能ETF华宝标的指数日内“V”型拉升。中际旭创、新易盛逆市上涨，高“光”指数V型拉升！*布局高“光”主线+AI应用，建议关注创业板人工智能ETF华宝及场外联接，重点布局光模块CPO龙头，兼顾AI应用。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2026-09-11/doc-inirnhrq6694331.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["AGIX","LCLG","VUSE","159363","ARTY","QID","PBOT","AAOZ","000001.SH","CNXT","GK","IBBQ","399006","NBDS","CHAT","KOMP","159915","159982","LYTE","515890","06978","AIFD","QQA","159992","LUMA","WPAI","MVPS","AQGX","DQJN","MFIG","399300","FDN","MEDX","QSWN","CPNQ","510300","161631","NEWZ","TARK","TECY","QTOC","159876","512510","AIBU","LNGR","FWD","CWC","AIQU","OGIG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666525651","title":"贝泰妮：注射用透明质酸钠溶液获得医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2666525651","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666525651?lang=zh_cn&edition=fundamental","pubTime":"2026-09-11 18:17","pubTimestamp":1789121838,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["MDEV","AGNG","LGHT","LNGR","RSPH","IEIH","HART","GDOC","PTH","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666230575","title":"东方生物：获得多项境外医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2666230575","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666230575?lang=zh_cn&edition=fundamental","pubTime":"2026-09-11 18:05","pubTimestamp":1789121126,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["MDEV","LNGR","AGNG","GDOC","LGHT","PTH","RSPH","HART","IEIH","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666544799","title":"九强生物：取得I型胶原氨基端延长肽测定试剂盒医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2666544799","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666544799?lang=zh_cn&edition=fundamental","pubTime":"2026-09-11 15:50","pubTimestamp":1789113020,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["AGNG","LNGR","IEIH","LGHT","MDEV","PTH","HART","GDOC","MEDX","RSPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666938544","title":"麦科田赴港上市：并购拼出的医疗器械版图，暗藏多重隐忧","url":"https://stock-news.laohu8.com/highlight/detail?id=2666938544","media":"新浪证券","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666938544?lang=zh_cn&edition=fundamental","pubTime":"2026-09-11 15:35","pubTimestamp":1789112100,"startTime":"0","endTime":"0","summary":"近日，麦科田正式开启港股全球发售。盈利脆弱性在 2026 年一季度进一步暴露，上市前夕再度出现 252.7 万元亏损。靠并购快速拼出业务版图的麦科田，即将站上港股资本市场。对于麦科田而言，如何完成并购资产的深度整合、夯实自主研发实力、化解商誉与渠道危机，将决定它能否从并购拼凑的企业，蜕变为具备内生竞争力的医疗器械公司。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/aigcy/2026-09-11/doc-inirmvzx5385233.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1100","XMMO","LNGR","02041","MYLD","RSPH","MEDX","LGHT","BK1574","159883","KCE","PTH","09996","BK4585","AGNG","IEIH","BK1583","GDOC","CALF","BK4588","HART","MDEV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666544925","title":"昂利康创新药引进项目告吹：授权合作折戟背后，主业承压研发布局遇变数","url":"https://stock-news.laohu8.com/highlight/detail?id=2666544925","media":"新浪证券","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666544925?lang=zh_cn&edition=fundamental","pubTime":"2026-09-11 15:35","pubTimestamp":1789112100,"startTime":"0","endTime":"0","summary":"9 月 6 日，昂利康发布公告宣布终止与亚飞生物、亲合力的 IMD\u001e1005肿瘤抗体药物授权许可合作。02主业盈利出现下滑，创新转型面临双重考验创新药引进受挫的同时，昂利康主业经营已经显现压力。原料药业务是昂利康的基本盘，业绩下滑说明核心主业易受行业周期、市场供需波动冲击，自身抗周期能力有待加强。未来昂利康既要稳固原料药基本盘，也需要平衡好资金投入与管线风险，审慎推进授权引进类项目。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/aigcy/2026-09-11/doc-inirmvzx5384750.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1574","IBBQ","BK0239","LNGR","MEDX","002940","06978","159992","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666544603","title":"一品红痛风创新药Ⅲ期临床达到主要终点 大中华区销售峰值预计达19.5亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2666544603","media":"新浪证券","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666544603?lang=zh_cn&edition=fundamental","pubTime":"2026-09-11 15:34","pubTimestamp":1789112040,"startTime":"0","endTime":"0","summary":"近日，一品红自愿披露关于痛风创新药AR882治疗痛风伴高尿酸血症患者Ⅲ期临床研究达到主要终点的公告。商业化权益方面，AR882为一品红自主研发的1类创新药，在大中华区拥有完整的开发、生产与商业化权益，且一品红具备成熟的自有慢病药商业化团队，无需对外支付销售分成。结合0.70的临床成功概率，最终AR882大中华区痛风适应症管线的风险调整净现值约为5.5亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/observe/2026-09-11/doc-inirmvzz2155509.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LNGR","BK1574","IBBQ","MEDX","300723","06978","BK0239","159992","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1114311100","title":"无AI增长：八大精选股票","url":"https://stock-news.laohu8.com/highlight/detail?id=1114311100","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1114311100?lang=zh_cn&edition=fundamental","pubTime":"2026-09-11 13:06","pubTimestamp":1789103219,"startTime":"0","endTime":"0","summary":"人工智能究竟是一场第四次工业革命，还是一个超级泡沫？答案取决于你听的是华尔街哪位预言家的高论。它或将开启一个超级生产力周期，或将引发崩盘——亦或是两者兼而有之。它将攻克疾病与贫困，除非它先降低了大规模毁灭的门槛。有时实在令人疲惫不堪。以下八只颇具前景的股票，幸运地与AI关联甚微。没有事件视界，我们有的是一场盛大的电子游戏发布。我们不敢保证这份名单100%与AI绝缘。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2106854487.HKD","LU0158827781.USD","MHIP","IE00BJLML261.HKD","IXJ","LU2264538146.SGD","SG9999014906.USD","IE00BWXC8680.SGD","LU0471298694.HKD","LU0130102774.USD","LU2237438978.USD","LU0385154629.USD","LU2461242641.AUD","LU2168564149.EUR","LU0321505439.SGD","LU0320765059.SGD","SGXZ31699556.SGD","LU0006306889.USD","LU2746668461.USD","LU0225771236.USD","LU2108987350.USD","LU1917777945.USD","LU0321505868.SGD","LU0353189680.USD","LU0079474960.USD","LU1057294990.SGD","LU0106831901.USD","BK4142","LU2168564495.EUR","IE00B7KXQ091.USD","BK4517","LU1074936037.SGD","LU2756315664.SGD","RCL","SG9999014898.SGD","SG9999001176.SGD","LU2417539215.USD","LU0225284248.USD","LU1551013425.SGD","LU0130517989.USD","RXL","LU0345774391.USD","LU2087625088.SGD","LU0471298777.SGD","LU0238689110.USD","LU0323591593.USD","LU1861220207.SGD","LU2028103732.USD","WDNA","IE00BJJMRY28.SGD","LU0114720955.EUR","LLII","LU2750360641.GBP","LU1868836757.USD","LU0048573561.USD","LU2211815571.USD","LU0096364046.USD","SG9999018857.SGD","LU0683600562.USD","LU1363072403.SGD","LU2462157665.USD","LU2360106947.USD","LU0477156953.USD","LU2746668974.SGD","BK4581","LU2471134523.USD","LU0251131958.USD","BK4127","LU1291159041.SGD","LU2063271972.USD","FTXH","IE00B4R5TH58.HKD","LU2357305700.SGD","BK4200","LU1668664300.SGD","IE00B2B36J28.USD","LU1988902786.USD","LU2471134796.USD","LU0251142724.SGD","LU1069347547.HKD","IE00B775H168.HKD","SCHW","LU1280957306.USD","LU0985481810.HKD","LU0203202063.USD","LU0061475181.USD","LU1868836591.USD","LU0306807586.USD","SG9999014880.SGD","IE0002141913.USD","LU1551013342.USD","TRUH","SG9999013999.USD","LU1989771016.USD","LU0266013472.USD","CANC","ILDR","OZEM","LU2462591350.SGD","LU1983299246.USD","AGNG","SGXZ57979304.SGD","LU0109391861.USD","LU2023250330.USD","VHT","IE00BN29S564.USD","LU0345770993.USD","BK4597","LU2471134952.CNY","LU2324357040.USD","IE00BKPKM429.USD","LU1064131342.USD","BK4533","LU2471134879.HKD","LU1267930730.SGD","LU2168563687.JPY","LU1868837136.USD","LU1023059063.AUD","BK4588","LU2237443549.SGD","BK4534","BK4161","LU2023250504.SGD","SG9999015945.SGD","IE0004445239.USD","LU1061106388.HKD","LU0133085943.USD","BK4589","LU2750360997.AUD","LU2552382058.USD","LU2361045086.USD","FIVE","SG9999014013.SGD","IE00BJJMRX11.SGD","LU1323610961.USD","IE00B4JS1V06.HKD","SG9999014021.USD","LU1868836914.USD","LU2213496289.HKD","GDOC","LU1127390331.HKD","LU0306806265.USD","LU0456855351.SGD","LU1153585028.USD","LU1720051108.HKD","SG9999015952.SGD","LU2552382132.HKD","ELIL","SG9999018865.SGD","LU1712237335.SGD","LU2896262040.SGD","LU0310800379.SGD","LU0210536198.USD","LU2089984988.USD","LU0122379950.USD","LU0203201768.USD","BK4516","LLYZ","BK4599","LU0158827948.USD","LU0058720904.USD","LU0225283273.USD","HRTS","LU1069344957.HKD","IE00BFSS8Q28.SGD","SG9999014005.SGD","LU0943347566.SGD","BK4585","IE0001KFT4U8.USD","MEDI","LU1720051017.SGD","IE00B19Z3581.USD","LU0640476718.USD","JDOC","LU2456880835.USD","LU0432979614.USD","SG9999014914.USD","CURE","LU1093756168.USD","ELIS","LU0256863902.USD","SG9999001176.USD","LU0354030438.USD","LU1232071149.USD","IHE","SG9999015986.USD","LU0234572021.USD","PJP","LU0971096721.USD","IE00B1XK9C88.USD","LU0109394709.USD","LU2112291526.USD","LU2602419157.SGD","LU0353189763.USD","BK4504","BK4007","IAI","LU0708995401.HKD","LU1629891620.HKD","LU1861217088.USD","LU0097036916.USD","LU2236285917.USD","LU0316494557.USD","LU0106261372.USD","SG9999001077.SGD","LU2237443978.SGD","LU0889565916.HKD","LU1670627923.USD","SGXZ99366536.SGD","IE00BK4W5L77.USD","LU0820562030.AUD","LU1093756325.SGD","IE00BFTCPJ56.SGD","SGXZ51526630.SGD","LU2360107671.USD","LU2168564065.EUR","LU0882574055.USD","LU0820561818.USD","LU2491050071.SGD","XLV","LU0823416689.USD","LU1791807156.HKD","LU0787776722.HKD","LU2111349929.HKD","LU0345770308.USD","LU1201861249.SGD","LU1814569148.SGD","SWK","LU1974910355.USD","IE00BK4W5M84.HKD","TMED","WNDR","FHLC","LU0417517546.SGD","IYH","LU0823434583.USD","LU1035775433.USD","LU2168564222.USD","LU1548497426.USD","IE00B1BXHZ80.USD","LU0823434740.USD","LU2552382215.SGD","LU0354030511.USD","LU0820561909.HKD","LU0964807845.USD","LU1868837300.USD","LU2237443895.HKD","IE00B7SZLL34.SGD","LU1691799644.USD","IE0002270589.USD","LU1035773651.USD","BK4139","LU0198837287.USD","LLY","LU1979441026.SGD","LU0320765992.SGD","IE0009355771.USD","MEDX","IE00BJT1NW94.SGD","IE00BFSS7M15.SGD","LU0708994859.HKD","LU2361044865.SGD","LU1623119135.USD","LU2237443622.USD","GB00BDT5M118.USD","LU2491050154.USD","LU0672654240.SGD","SG9999017495.SGD","IE0004445015.USD","LU0980610538.SGD","LU0882574139.USD","LU2089284900.SGD","IE00B19Z3B42.SGD","LU0786609619.USD","LU1366192091.USD","SG9999015978.USD","IE000M9KFDE8.USD","LU1670628061.USD","LU0289739699.SGD","LU2491049909.HKD","IE0005OL40V9.USD","BMRN","LU2089283258.USD","LU0689472784.USD","LU2756315318.SGD","PPH","LU2361044949.HKD","LU0256863811.USD","LU2271345857.HKD","LU0128525929.USD","SG9999014039.USD","BK4566","THNR","LU0029864427.USD","LU0466842654.USD","LU0094547139.USD","LU2468319806.SGD","SGXZ81514606.USD","LU0648001328.SGD","LU2237443465.HKD","LU1145028129.USD","LU1267930573.SGD","LU2023251221.USD","LU2265009873.SGD","IE00BKDWB100.SGD","LU0174119429.USD","IE00BJJMRZ35.SGD","LU0345774631.USD","LLYX","LU0742534661.SGD","LU2237443382.USD","LU0011850046.USD","LU1804176565.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666510786","title":"港股异动 | 创新药概念股持续调整 海外利率预期反复 2026国谈收官进入结果等待期","url":"https://stock-news.laohu8.com/highlight/detail?id=2666510786","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666510786?lang=zh_cn&edition=fundamental","pubTime":"2026-09-11 11:08","pubTimestamp":1789096112,"startTime":"0","endTime":"0","summary":"消息面上，2026国谈现场谈判和价格协商收官，正式进入结果等待期。新版国家基本医保药品目录与商保创新药目录预计11月正式公布，2027年1月1日起统一执行。此外，能源供给风险急剧升温，10年期美债收益率攀升至近三年高位，市场定价美联储下周加息25BP的概率已升至约70%。分析人士指出，近期创新药板块的调整，主要受到海外利率预期反复、油价上行推升通胀担忧、临床风险事件扰动及资金风格轮动等因素影响。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1494833.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","LU1813983027.USD","BK4585","LNGR","LU0326950275.SGD","LU2097828805.USD","LU2097828557.USD","LU0501845795.SGD","BK1191","LU1226287875.USD","MCRO","LU1188198961.HKD","LU0067412154.USD","KURE","IBBQ","LU0455707207.USD","01801","LU1328277881.USD","BK1515","LU0149534421.HKD","LU0244354667.USD","LU1226287792.SGD","WRTH","LU0072913022.USD","02157","LU2242644610.SGD","LU2097828474.EUR","06978","LU1807302812.USD","IE0008369823.USD","09995","159992","MEDX","LU2488822045.USD","LU1831875114.USD","IE0008368742.USD","01093","KCAI","LU1960683339.HKD","BK1589","LU0880133367.SGD","LU1008478684.HKD","VXUS","IE00BZ08YS42.EUR","LU2328871848.SGD","PEVC","LU1226288170.HKD","LU1969619763.USD","IE00BZ08YT58.USD","IE00B5MMRT66.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666510878","title":"百龙创园在昆明成立生物科技公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2666510878","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666510878?lang=zh_cn&edition=fundamental","pubTime":"2026-09-11 10:32","pubTimestamp":1789093959,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["GDOC","IBBJ","BK4588","SYNB","IEIH","LNGR","MEDX","BK4585","BK4581","AGNG","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666517543","title":"港股异动 | 先健科技(01302)涨超3% LantvalTM主动脉瓣膜置换系统进入创新医疗器械特别审查程序","url":"https://stock-news.laohu8.com/highlight/detail?id=2666517543","media":"智通财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666517543?lang=zh_cn&edition=fundamental","pubTime":"2026-09-11 09:49","pubTimestamp":1789091380,"startTime":"0","endTime":"0","summary":"消息面上，先健科技发布公告，于2026年9月9日，本公司收到国家药品监督管理局的正式书面通知，确认由本公司附属公司深圳市健心医疗科技有限公司与国家心血管病中心中国医学科学院阜外医院联合研发的LantvalTM主动脉瓣膜置换系统进入国家药品监督管理局创新医疗器械特别审查程序。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1494794.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["MEDX","KCAI","BK4585","AGNG","HART","GDOC","BK1574","09996","BK1583","01302","LGHT","PTH","LNGR","BK1600","BK1100","159883","IEIH","BK4588","MDEV","VXUS","RSPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666127155","title":"【券商聚焦】中信建投：医疗器械板块业绩有望逐步改善","url":"https://stock-news.laohu8.com/highlight/detail?id=2666127155","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666127155?lang=zh_cn&edition=fundamental","pubTime":"2026-09-11 09:18","pubTimestamp":1789089493,"startTime":"0","endTime":"0","summary":"金吾财讯 | 中信建投证券研究指，医疗器械板块Q2收入延续增长趋势，单季度利润增速四年来首次转正。该机构认为，随着集采影响逐步出清叠加创新驱动和海外业务加速的双重助力，医疗器械板块业绩有望逐步改善。尽管季度业绩增速可能有所波动，Q3能否相比Q2加速尚不确定，但大趋势来看，26和27年年度业绩持续改善的确定性较强。","market":"nz","thumbnail":"https://static.szfiu.com/news/20241108/MDc2YjQxZmY4Y2VkNWEzNDU4MmJiNGExMDgxOTA3MjUwMzc=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/MDc2YjQxZmY4Y2VkNWEzNDU4MmJiNGExMDgxOTA3MjUwMzc=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"299f0a9977df499f8ead781071e5e5e7","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1991348","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01302","00241","BK1247","BK1502","601066","BK1161","BK1584","BK1610","LU0173614495.USD","BK1501","BK1585","BK1100","BK1571","BK1589","BK1615","BK1600","LNGR","LU0287142896.SGD","BK1593","02235","BK1591","RSPH","MEDX","HK0000165453.HKD","LGHT","BK1574","BK1587","BK1617","02252","159883","KCE","BK1515","00853","01066","BK1189","PTH","BK0276","BK1142","HART","09996","BK1222","IEIH","AGNG","BK1583","GDOC","02190","06826","MDEV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666983512","title":"深港携手拓全球药械市场，2026深圳国际高性能医疗器械展举行","url":"https://stock-news.laohu8.com/highlight/detail?id=2666983512","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666983512?lang=zh_cn&edition=fundamental","pubTime":"2026-09-11 09:10","pubTimestamp":1789089045,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LGHT","PTH","RSPH","BK1583","BK1507","BK1185","LU0067412154.USD","BK1582","GDOC","HART","MDEV","MEDX","IEIH","00152","BK1100","LU1152091754.HKD","159883","LU1008478684.HKD","09996","LNGR","BK1574","SG9999003461.SGD","LU0880133367.SGD","AGNG","LU1152091168.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666751737","title":"涉IPO操纵嫌疑，香港证监会强制眼科创新药公司拨康视云停牌，最牛天使投资人富豪龚虹嘉是站台的基石投资者","url":"https://stock-news.laohu8.com/highlight/detail?id=2666751737","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666751737?lang=zh_cn&edition=fundamental","pubTime":"2026-09-11 08:17","pubTimestamp":1789085820,"startTime":"0","endTime":"0","summary":"停牌前，拨康视云报1.19港元，较2025年7月上市发行价10.1港元，累计蒸发约88%。这是一间成立于2015年、专注眼科创新药的临床阶段生物科技公司，四次递表才闯关成功，上市首日即告破发，如今在监管介入调查中股票停牌，前路未卜。证监会表示，调查仍在进行中，暂不作进一步评论。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/2026-09-11/doc-inirmfea2271775.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["KCE","IPOS","BK4127","REDS","159992","MEDX","BK1574","LNGR","BK1161","FRHC","06978","IBBQ","02592"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666511370","title":"国产创新药新适应症密集获批 “一药拓多域”重塑行业成长逻辑","url":"https://stock-news.laohu8.com/highlight/detail?id=2666511370","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666511370?lang=zh_cn&edition=fundamental","pubTime":"2026-09-11 07:32","pubTimestamp":1789083145,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["06978","IBBQ","BK1161","MEDX","159992","BK1574","LNGR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666519089","title":"国产创新药新适应症密集获批 “一药拓多域”重塑行业成长逻辑","url":"https://stock-news.laohu8.com/highlight/detail?id=2666519089","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666519089?lang=zh_cn&edition=fundamental","pubTime":"2026-09-11 07:15","pubTimestamp":1789082138,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["MEDX","IBBQ","LNGR"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":13,"pageCount":4,"totalSize":241,"code":"91000000","status":"200"}]}}